Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Mangifera indica
Pan-tropical fruit tree; bark, leaves, and seed kernels used medicinally across Asia and Africa.
Mangifera indica (mango) is a pan-tropical fruit tree whose bark, leaves, and seed kernels are used in traditional Asian and African medicine. It is primarily employed for its antidiabetic, antioxidant, anti-inflammatory, and antimicrobial properties, with key active compounds including mangiferin, quercetin, kaempferol, and gallic acid. Evidence level C indicates limited clinical data, but preclinical and traditional use support its therapeutic potential.
Mangiferin, a xanthone C-glycoside, inhibits α-glucosidase and aldose reductase, reducing postprandial hyperglycemia and preventing diabetic complications. It also activates AMPK and PPAR-γ, improving insulin sensitivity and glucose uptake. Quercetin and kaempferol exert antioxidant effects via Nrf2 pathway activation and scavenging of reactive oxygen species. Anti-inflammatory actions involve suppression of NF-κB, COX-2, and iNOS, while antimicrobial activity is attributed to membrane disruption and inhibition of bacterial efflux pumps.
Pan-tropical fruit tree; bark, leaves, and seed kernels used medicinally across Asia and Africa.
Mangifera indica (mango) is a pan-tropical fruit tree whose bark, leaves, and seed kernels are used in traditional Asian and African medicine. It is primarily employed for its antidiabetic, antioxidant, anti-inflammatory, and antimicrobial properties, with key active compounds including mangiferin, quercetin, kaempferol, and gallic acid. Evidence level C indicates limited clinical data, but preclinical and traditional use support its therapeutic potential.
Mangiferin, a xanthone C-glycoside, inhibits α-glucosidase and aldose reductase, reducing postprandial hyperglycemia and preventing diabetic complications. It also activates AMPK and PPAR-γ, improving insulin sensitivity and glucose uptake. Quercetin and kaempferol exert antioxidant effects via Nrf2 pathway activation and scavenging of reactive oxygen species. Anti-inflammatory actions involve suppression of NF-κB, COX-2, and iNOS, while antimicrobial activity is attributed to membrane disruption and inhibition of bacterial efflux pumps.